HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 – Clinical Trial Not Allowed)
Funds initial translational efforts that will enable a drug discovery program for novel, non-opioid, and non-addictive treatments for pain. Funding to develop and validate assays to support a distinct testing funnel and conduct screening efforts to identify and characterize potential therapeutic agents including small molecules, biologics, and natural products. [Posted 9/18/2024. Expires 1/16/2027]